MMSL 2023, 92(4):356-366 | DOI: 10.31482/mmsl.2022.055

ANTI-INFLAMMATORY ACTIVITY OF PLATELET-RICH PLASMA TREATMENT IN THE INFLAMMATION MANAGEMENT OF KNEE OSTEOARTHRITIS: EXPERIMENTAL STUDYOriginal article

Haider A. Yousif, Ajil A. Alzamily ORCID...*, Ihsan A. Alsalman ORCID...
College of Medicine, University of AL-Qadisiyah, Iraq

Background: The level of pro-inflammatory Cluster of Differentiation 68 (CD 68) could be beneficial for examination as a biomarker for identifying cartilage or knee tissue degradation in joint problems. Because Cluster of Differentiation 68 appears to be linked to cell damage in the injury area, its measurement may be an effective and sensitive tool for detecting the early development of knee osteoarthritis (KOA) in people at risk for knee osteoarthritis.Aim of the study: The study aimed to evaluate which type of PRP (Pure-PRP and leukocyte-PRP) are suitable for patients with KOA via assessing the levels of serum CD 68 concentration.

Materials and Methods: Serum Cluster of Differentiation 68 level was computed using ELISA kits. The experimental study comprises 21 pure-platelet-rich plasma (P-PRP) injections,11 leukocytes platelet-rich plasma (L-PRP) injections, and  16 control groups. Ranged from 35- 75 years old. All patients with diabetes mellitus, autoimmune disease, and severe knee osteoarthritis were excluded from this study. The period of the study was between November 2021 to June 2022. This study assessed other factors such as age, sex, family inheritance, and body mass index (BMI). The level of CD 68 was measured in the serum before and after the injection for six weeks.

Results: The level of the study showed CD 68 elevated before injection in patients with knee osteoarthritis. A significant decrease of CD 68 (P< 0.01-P<0.001) in the serum concentration after injection as compared to before injection. However, the concentration was significantly higher than the control.

Conclusions: In conclusion, both P-PRP and L-PRP demonstrated anti-inflammatory properties. Patients in both groups experienced a significant decrease in CD 68 serum levels, however, the P-PRP was more effective than the L-PRP.

Keywords: platelet-rich plasma (PRP); Osteoarthritis (OA); Cluster of Differentiation 68 (CD 68); Pro-inflammatory

Received: July 9, 2022; Revised: December 9, 2022; Accepted: December 12, 2022; Prepublished online: February 8, 2023; Published: December 1, 2023  Show citation

ACS AIP APA ASA Harvard Chicago IEEE ISO690 MLA NLM Turabian Vancouver
Yousif, H.A., Alzamily, A.A., & Alsalman, I.A. (2023). ANTI-INFLAMMATORY ACTIVITY OF PLATELET-RICH PLASMA TREATMENT IN THE INFLAMMATION MANAGEMENT OF KNEE OSTEOARTHRITIS: EXPERIMENTAL STUDY. MMSL92(4), 356-366. doi: 10.31482/mmsl.2022.055
Download citation

References

  1. Gao L, Madry H, Chugaev DV, et al. Advances in modern osteotomies around the knee. Journal of experimental orthopaedics. 2019;6(1):1-4. https://doi.org/10.1186/s40634-019-0177-5. Go to original source... Go to PubMed...
  2. Walls RJ, Ross KA, Fraser EJ, et al. Football injuries of the ankle: A review of injury mechanisms, diagnosis and management. World journal of orthopedics. 2016 Jan 18;7(1):8. Go to original source... Go to PubMed...
  3. Teixeira SP, Domingues RM, Shevchuk M, et al. Biomaterials for sequestration of growth factors and modulation of cell behaviour. Advanced Functional Materials. 2020;30(44):1909011. https://doi.org/10.1002/adfm.201909011 Go to original source...
  4. Stoddart JC, Dandridge O, Garner A, et al. The compartmental distribution of knee osteoarthritis-a systematic review and meta-analysis. Osteoarthritis and Cartilage. 2021;29(4):445-455. https://doi.org/10.1016/j.joca.2020.10.011 Go to original source... Go to PubMed...
  5. Rezuș E, Cardoneanu A, Burlui A, et al. The link between inflammation and degenerative joint diseases. International journal of molecular sciences. 2019;20(3):614. https://doi.org/10.3390/ijms20030614 Go to original source... Go to PubMed...
  6. Patel S, Dhillon MS, Aggarwal S, et al. Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial. The American journal of sports medicine. 2013;41(2):356-364. https://doi.org/10.1177/0363546512471299 Go to original source... Go to PubMed...
  7. Abu-Ghname A, Perdanasari AT, Davis MJ, et al. Platelet-rich plasma: principles and applications in plastic surgery. Seminars in plastic surgery. Semin Plast Surg 2019; 33(03): 155-161. https://doi.org/10.1055/s-0039-1693400. Go to original source... Go to PubMed...
  8. Stevens J, Khetarpal S. Platelet-rich plasma for androgenetic alopecia: a review of the literature and proposed treatment protocol. International journal of women's dermatology. 2019;5(1):46-51. https://doi.org/10.1016/j.ijwd.2018.08.004. Go to original source... Go to PubMed...
  9. Jones IA, Togashi R, Wilson ML, et al. Intra-articular treatment options for knee osteoarthritis. Nature Reviews Rheumatology. 2019;15(2):77-90. https://doi.org/10.1038/s41584-018-0123-4. Go to original source... Go to PubMed...
  10. Garbin LC, Olver CS. Platelet-rich products and their application to osteoarthritis. Journal of equine veterinary science. 2020;86:102820. https://doi.org/10.1016/j.jevs.2019.102820. Go to original source... Go to PubMed...
  11. Spaková T, Rosocha J, Lacko M, et al. Treatment of knee joint osteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid. American Journal of Physical Medicine & Rehabilitation. 2012;91(5):411-417. https://doi.org/10.1097/PHM.0b013e3182aab72. Go to original source... Go to PubMed...
  12. Toosi S, Behravan J. Osteogenesis and bone remodeling: A focus on growth factors and bioactive peptides. Biofactors. 2020;46(3):326-340.https://doi.org/10.1002/biof.1598. Go to original source... Go to PubMed...
  13. Aminkov KB, Mehandzhiyski NH, Aminkov BY, et al. Application of platelet-rich plasma for canine osteoarthritis treatment-a clinical series. Bulgarian Journal of Veterinary Medicine. 2021;24(4). https://doi.org/10.15547/bjvm.2019-0095. Go to original source...
  14. Gentile P, Alves R, Cole JP, et al. AIRMESS-Academy of International Regenerative Medicine & Surgery Societies: recommendations in the use of platelet-rich plasma (PRP), autologous stem cell-based therapy (ASC-BT) in androgenetic alopecia and wound healing. Expert Opinion on Biological Therapy. 2021;21(11):1443-1449. https://doi.org/10.1080/14712598.2021.1908995. Go to original source... Go to PubMed...
  15. Lu M, Lezzar DL, Vörös E, et al. Traditional and emerging technologies for washing and volume reducing blood products. Journal of Blood Medicine. 2019;10:37. https://doi.org/10.2147/JBM.S166316. Go to original source... Go to PubMed...
  16. Liu C, Huang B, Wang H, et al. The heterogeneity of megakaryocytes and platelets and implications for ex vivo platelet generation. Stem Cells Translational Medicine. 2021;10(12):1614-1620. https://doi.org/10.1002/sctm.21-0264. Go to original source... Go to PubMed...
  17. Davizon-Castillo P, Rowley JW, Rondina MT. Megakaryocyte and platelet transcriptomics for discoveries in human health and disease. Arteriosclerosis, thrombosis, and vascular biology. 2020;40(6):1432-1440. https://doi.org/10.1161/ATVBAHA.119.313280. Go to original source... Go to PubMed...
  18. Cook CS, Smith PA. Clinical update: why PRP should be your first choice for injection therapy in treating osteoarthritis of the knee. Current reviews in musculoskeletal medicine. 2018;11(4):583-592. https://doi.org/10.1007/s12178-018-9524-x Go to original source... Go to PubMed...
  19. Lopes D, Martins-Cruz C, Oliveira MB, et al. Bone physiology as inspiration for tissue regenerative therapies. Biomaterials. 2018;185:240-275. https://doi.org/10.1016/j.biomaterials.2018.09.028. Go to original source... Go to PubMed...
  20. Cecerska-Heryć E, Goszka M, Serwin N, et al. Applications of the regenerative capacity of platelets in modern medicine. Cytokine & Growth Factor Reviews. 2021. https://doi.org/10.1016/j.cytogfr.2021.11.003. Go to original source... Go to PubMed...
  21. Kennon JC, Awad ME, Chutkan N, et al. Current insights on use of growth factors as therapy for intervertebral disc degeneration. Biomolecular Concepts. 2018;9(1):43-52. https://doi.org/10.1515/bmc-2018-0003. Go to original source... Go to PubMed...
  22. Shah SS, Mithoefer K. Current applications of growth factors for knee cartilage repair and osteoarthritis treatment. Current Reviews in Musculoskeletal Medicine. 2020;13(6):641-650. https://doi.org/10.1007/s12178-020-09664-6. Go to original source... Go to PubMed...
  23. Braun HJ, Wasterlain AS, Dragoo JL. The use of PRP in ligament and meniscal healing. Sports Medicine and Arthroscopy Review. 2013;21(4):206-212. https://doi.org/10.1097/JSA.0000000000000005. Go to original source... Go to PubMed...
  24. Abd-Elsayed A. Stem cells for the treatment of knee osteoarthritis: a comprehensive review. Pain Physician. 2018;21:229-241. Go to original source... Go to PubMed...
  25. Mohd Noor NA, Abdullah Nurul A, Ahmad Mohd Zain MR, et al. Extracellular vesicles from mesenchymal stem cells as potential treatments for osteoarthritis. Cells. 2021;10(6):1287. https://doi.org/10.3390/cells10061287. Go to original source... Go to PubMed...
  26. Whitney KE, Liebowitz A, Bolia IK, et al. Current perspectives on biological approaches for osteoarthritis. Annals of the New York Academy of Sciences. 2017;1410(1):26-43. https://doi.org/10.1111/nyas.13554. Go to original source... Go to PubMed...
  27. Mariani E, Canella V, Cattini L, et al. Leukocyte-rich platelet-rich plasma injections do not up-modulate intra-articular pro-inflammatory cytokines in the osteoarthritic knee. PLoS One. 2016;11(6):e0156137. https://doi.org/10.1371/journal.pone.0156137. Go to original source... Go to PubMed...
  28. Abrams GD, Frank RM, Fortier LA, et al. Platelet-rich plasma for articular cartilage repair. Sports medicine and arthroscopy review. 2013;21(4):213-219. Go to original source... Go to PubMed...
  29. Kennedy MI, Whitney K, Evans T, et al. Platelet-rich plasma and cartilage repair. Current reviews in musculoskeletal medicine. 2018;11(4):573-582. https://doi.org/10.1007/s12178-018-9516-x. Go to original source... Go to PubMed...
  30. Borriello A, Caldarelli I, Bencivenga D, et al. Tyrosine kinase inhibitors and mesenchymal stromal cells: effects on self-renewal, commitment and functions. Oncotarget. 2017;8(3):5540. https://doi.org/10.18632/oncotarget.12649. Go to original source... Go to PubMed...
  31. Zernecke A, Winkels H, Cochain C, et al. Meta-analysis of leukocyte diversity in atherosclerotic mouse aortas. Circulation research. 2020;127(3):402-426. https://doi.org/10.1161/CIRCRESAHA.120.316903 Go to original source... Go to PubMed...
  32. Fan XL, Zhang Y, Li X, et al. Mechanisms underlying the protective effects of mesenchymal stem cell-based therapy. Cellular and molecular life sciences. 2020;77(14):2771-2794. https://doi.org/10.1007/s00018-020-03454-6. Go to original source... Go to PubMed...
  33. Pridans C, Raper A, Davis GM, et al. Pleiotropic impacts of macrophage and microglial deficiency on development in rats with targeted mutation of the Csf1r locus. The Journal of Immunology. 2018;201(9):2683-99. https://doi.org/10.4049/jimmunol.1701783. Go to original source... Go to PubMed...
  34. Chistiakov DA, Killingsworth MC, Myasoedova VA, et al. CD68/macrosialin: not just a histochemical marker. Laboratory investigation. 2017;97(1):4-13. https://doi.org/10.1038/labinvest.2016.116. Go to original source... Go to PubMed...
  35. Zhang X, Huang F, Li W, et al. Human gingiva-derived mesenchymal stem cells modulate monocytes/macrophages and alleviate atherosclerosis. Frontiers in immunology. 2018;9:878. https://doi.org/10.3389/fimmu.2018.00878 Go to original source... Go to PubMed...
  36. Pombinho R, Sousa S, Cabanes D. Scavenger receptors: promiscuous players during microbial pathogenesis. Critical reviews in microbiology. 2018;44(6):685-700. https://doi.org/10.1080/1040841X.2018.1493716. Go to original source... Go to PubMed...
  37. Basak I, Wicky HE, McDonald KO, et al. A lysosomal enigma CLN5 and its significance in understanding neuronal ceroid lipofuscinosis. Cellular and Molecular Life Sciences. 2021;78(10):4735-4763. Go to original source... Go to PubMed...
  38. Patten DA, Wilkinson AL, O'Keeffe A, et al. Scavenger receptors: novel roles in the pathogenesis of liver inflammation and cancer. InSeminars in Liver Disease 2022 (Vol. 42, No. 01, pp. 061-076). https://doi.org/10.1055/s-0041-1733876. Go to original source... Go to PubMed...
  39. Alzamily AA, Al-Delfi MN, Al-Barqaw AR. A role for inflammatory il-6 in the development of coronary artery disease: a case control study at al-qadisiyah governorate, IRAQ. MMSL. 2022;91(4):293-304. https://doi.org/10.31482/mmsl.2022.005. Go to original source...
  40. Devaraj AK, Acharya KK, Adhikari R. Comparison of biomechanical parameters between medial and lateral compartments of human knee joints. The Open Biomedical Engineering Journal. 2020;14(1). https://doi.org/10.2174/1874120702014010074. Go to original source...
  41. Karpiński R, Jaworski Ł, Jonak J, et al. Stress distribution in the knee joint in relation to tibiofemoral angle using the finite element method. EDP Sciences. InMATEC Web of Conferences 2019; Vol. 252, p. 07007. https://doi.org/10.1051/matecconf/201925207007 Go to original source...
  42. Szwedowski D, Szczepanek J, Paczesny Ł, et al. The effect of platelet-rich plasma on the intra-articular microenvironment in knee osteoarthritis. International Journal of Molecular Sciences. 2021;22(11):5492. https://doi.org/10.3390/ijms22115492. Go to original source... Go to PubMed...
  43. Sánchez M, Anitua E, Azofra J, et al. Intra-articular injection of an autologous preparation rich in growth factors for the treatment of knee OA: a retrospective cohort study. Clin Exp Rheumatol. 2008;26(5):910-913. Go to PubMed...
  44. Duymus TM, Mutlu S, Dernek B, et al. Choice of intra-articular injection in treatment of knee osteoarthritis: platelet-rich plasma, hyaluronic acid or ozone options. Knee surgery, sports traumatology, arthroscopy. 2017;25(2):485-492. https://doi.org/10.1007/s00167-016-4110-5. Go to original source... Go to PubMed...
  45. Filardo G, Kon E, Di Martino A, et al. Platelet-rich plasma vs hyaluronic acid to treat knee degenerative pathology: study design and preliminary results of a randomized controlled trial. BMC musculoskeletal disorders. 2012;13(1):1-8. https://doi.org/10.1186/1471-2474-13-229. Go to original source... Go to PubMed...
  46. Khatab S, van Buul GM, Kops N, et al. Intra-articular injections of platelet-rich plasma releasate reduce pain and synovial inflammation in a mouse model of osteoarthritis. The American journal of sports medicine. 2018;46(4):977-986. https://doi.org/10.1177/0363546517750635. Go to original source... Go to PubMed...
  47. Lynch TS, O'Connor M, Minkara AA, et al. Biomarkers for femoroacetabular impingement and hip osteoarthritis: a systematic review and meta-analysis. The American journal of sports medicine. 2019;47(9):2242-2250. https://doi.org/10.1177/0363546518803360. Go to original source... Go to PubMed...
  48. Micklem K, Rigney E, Cordell J, et al. A human macrophage-associated antigen (CD68) detected by six different monoclonal antibodies. British journal of haematology. 1989;73(1):6-11. https://doi.org/10.1111/j.1365-2141.1989.tb00210.x. Go to original source... Go to PubMed...
  49. Pulford KA, Sipos A, Cordell JL, et al. Distribution of the CD68 macrophage/myeloid associated antigen. International immunology. 1990;2(10):973-980. https://doi.org/10.1093/intimm/2.10.973. Go to original source... Go to PubMed...
  50. Athanasou NA, Quinn J. Immunophenotypic differences between osteoclasts and macrophage polykaryons: immunohistological distinction and implications for osteoclast ontogeny and function. Journal of clinical pathology. 1990;43(12):997-1003. http://dx.doi.org/10.1136/jcp.43.12.997. Go to original source... Go to PubMed...
  51. Pomilio C, Gorojod RM, Riudavets M, et al. Microglial autophagy is impaired by prolonged exposure to β-amyloid peptides: Evidence from experimental models and Alzheimer's disease patients. Geroscience. 2020;42(2):613-632. https://doi.org/10.1007/s11357-020-00161-9. Go to original source... Go to PubMed...
  52. Chen L, Merkhan MM, Forsyth NR, et al. Chorionic and amniotic membrane-derived stem cells have distinct, and gestational diabetes mellitus independent, proliferative, differentiation, and immunomodulatory capacities. Stem Cell Research. 2019;40:101537. https://doi.org/10.1016/j.scr.2019.101537 Go to original source... Go to PubMed...
  53. Narayanasamy KK, Price JC, Merkhan M, et al. Cytotoxic effect of PEI-coated magnetic nanoparticles on the regulation of cellular focal adhesions and actin stress fibres. Materialia. 2020;13:100848. https://doi.org/10.1016/j.mtla.2020.100848 Go to original source...
  54. Shephard MT, Merkhan MM, Forsyth NR. Human Mesenchymal Stem Cell Secretome Driven T Cell Immunomodulation Is IL-10 Dependent. International Journal of Molecular Sciences. 2022;23(21):13596. https://doi.org/10.3390/ijms232113596 Go to original source... Go to PubMed...
  55. Forsyth NR, Steeg R, Ahmad M, et al. Mimicking Physiological Oxygen in Cell Cultures. InCell Culture Technology 2018 (pp. 129-137). Springer, Cham. https://doi.org/10.1007/978-3-319-74854-2_8 Go to original source...
  56. Merkhan MM, Shephard MT, Forsyth NR. Physoxia alters human mesenchymal stem cell secretome. Journal of Tissue Engineering. 2021;12:20417314211056132. https://doi.org/10.1177/20417314211056132 Go to original source... Go to PubMed...
  57. Sulaiman EA, Dhia S, Merkhan MM. Overview of vitamin d role in polycystic ovarian syndrome. MMSL. 2022;91(1):37-43. https://doi.org/10.31482/mmsl.2021.027 Go to original source...
  58. Abdullah E, Merkhan MM, Althanoon ZA. Osteoporosis: review of treatment modalities. IJRMST. 2021; 12(2): 34-46. https://doi.org/10.37648/ijrmst.v11i02.003 Go to original source...